Feline injection-site sarcomas were initially described by Hendrick and Goldschmidt (1991). The link between vaccination site and sarcoma occurrence suggested the term of vaccine-associated sarcomas. Our paper describes an unusual feline injection-site fi brosarcoma with cerebellar metastasis. A 7-year-old female domestic short-hair cat was submitted to the Pathology Department (Faculty of Veterinary Medicine ClujNapoca, Romania) for necropsy. A subcutaneous tumor (relapse) in the interscapular region and multiple metastatic masses in the lungs, kidneys, subcutaneous tissue (scapular and thigh regions) and cerebellum were observed. Cytological, histological and immunohistochemical (for vimentin, desmin, multi-cytokeratin, α-smooth muscle actin, S100 and CD45) analyses from all tumors were performed. Cytological examination identifi ed highly pleomorphic spindle-shaped cells admixed with neoplastic multinucleated giant cells. Histologically, all neoplastic masses were composed of numerous spindle cells arranged into interlacing bundles. Extensive intratumoral areas of necrosis along with a neutrophilic infi ltrate were also detected. A fi brillary material was present among neoplastic cells (green stained by Masson's trichrome method), suggesting a collagenous structure. In all tumors assessed, immunohistochemistry showed an intense reaction only for vimentin in numerous neoplastic cells. Based on the history, gross, cytological, histological and immunohistochemical data, the fi nal diagnosis was recurrent feline injection-site fi brosarcoma, with multiple metastases (including in the cerebellum). Overall, an uncommon case of feline injection-site fi brosarcoma has been reported. This is the fi rst consistent record of an injection site sarcoma in a cat with cerebellar metastasis.
INTRODUCTION
Feline injection-site sarcomas (FISS) were initially described by Hendrick and Goldschmidt (1991) [1] . The link between vaccination and the increased incidence of sarcoma occurrence, suggested the term of vaccine-associated sarcomas (or injectionsite sarcomas). However, recent studies showed that other foreign materials injected in the muscular or subcutaneous tissues can trigger a local chronic infl ammation and neoplastic transformation [2] . In most circumstances, FISS were associated with inactivated anti-rabies and anti-feline leukemia virus vaccines. Both vaccine types contain aluminum as adjuvant [3, 4] that is capable to trigger a chronic infl ammation (i.e., granulomatous reaction) at the site of vaccination [4, 5] . However, some reports demonstrated no signifi cant difference in the incidence of sarcomas with regard to vaccines with or without adjuvant materials [4, 6] . The prevalence of FISS in vaccinated subjects range from 1/1.000 to 1/10.000 [7, 8] . FISS are regularly occurring in 10 years old subjects (average age), with some peaks in 6-7 and 10-11 years old cats, respectively. A slightly higher incidence was noticed in females compared to males; no breed predisposition was observed [4, 6, 9, 10] .
The current report describes an unusual feline site-injection fi brosarcoma (FSIF) with cerebellar metastasis. According to our knowledge, this is the fi rst report of a FISS in the central nervous system.
CASE PRESENTATION Case History
A 7-year-old neutered female domestic short-hair cat was sent to the Pathology Department, Faculty of Veterinary Medicine Cluj-Napoca (Romania), for a complete necropsy survey. The cat was neutered at the age of two years. In 2015, the cat displayed a tumor in the interscapular region (i.e., vaccination site) that was surgically removed. The mass was diagnosed histologically as FISS. Six months later the cat presented respiratory distress and neurological signs (e.g., ataxia, abnormal positions of the head, ingestion failure etc.). Due to welfare reasons, the cat was humanely euthanized.
Necropsy
Grossly, the cat presented anemia and cachexia; in the subcutaneous tissue of the interscapular region, a fi rm, white-gray, nodular mass was detected ( Figure 1A ). The tumor had 1.1 cm in size with a central necrotic area in cross section. Similar nodular lesions affecting the kidneys (Figure 1B) , the left lobe of the cerebellum ( Figure 1C ) and the lungs ( Figure 1D ) were present. The pulmonary nodules had about 0.3-1 cm; renal masses ranged from 0.2 to 0.7 cm in diameter, while the cerebellar tumor had 1.2 cm/1 cm. Additionally, two more metastases were identifi ed in the subcutaneous tissue (a mass was located in the left thigh region -1.8/1.6 cm in diameter, and another one in the right scapular region -0.9/0.7 cm in size).
Cytology and histopathology
Cytological smears were performed from all nodular lesions using touch imprint method and were stained by Dia Quick Panoptic technique (DQP, Reagens Kft, Budapest, Hungary). Cytological examination identifi ed a large number of poorly differentiated spindle neoplastic cells, disposed individually or in groups. Numerous neoplastic multinucleated giant cells were also observed ( Figure 2A) ; a high number of tumor cells were in the mitotic phase (29 mitoses/10 HPF). The cytological features described above are compatible with the diagnosis of a malignant mesenchymal tumor (sarcoma).
For histology, the tumor samples were fi xed in 10% phosphate buffered formalin (pH 7.0) for 24 hours and routinely processed by paraffi n technique. The achieved slides were stained by hematoxylin-eosin (HE) and Masson's trichrome (MT) methods. The recurrent interscapular mass was well demarcated, unencapsulated, highly cellular and mainly composed of spindle cells arranged into variably-sized interlacing bundles. Neoplastic cells showed poorly defi ned borders, small amount of pale eosinophilic and slightly fi brillar cytoplasm, oval to elongate and vesicular nuclei, and 1-3 prominent variably-sized magenta nucleoli ( Figure 2B ). Multifocally, some multinucleated neoplastic cells were observed. A high number of mitotic fi gures were identifi ed (105 mitoses/10 HPF), some of them showing atypical features. An eosinophilic fi brillary material was present among neoplastic cells of the tumor. The fi brillary material was stained in green by Masson's trichrome method, suggesting a collagenous structure ( Figure 2D ). Peripherally, the tumor was multifocally infi ltrated by aggregates of lymphocytes ( Figure 2B ). However, in the central part of the tumor, extensive areas of necrosis along with neutrophilic infi ltrate and hemorrhages were observed. All the other masses identifi ed in the carcass (including the one in the cerebellum) presented the same histological features described above ( Figure 2C ). The cerebellar mass was unencapsulated, infi ltrative and poorly delimited from the adjacent nervous tissue. 
Immunohistochemistry
Immunohistochemistry was used to establish the fi nal diagnosis and origin of all tumors identifi ed throughout the body. Accordingly, the histological sections achieved by the paraffi n technique were utilized; the panel of antibodies applied on the slides were: vimentin (mouse anti-human monoclonal vimentin antibody, clone SRL33, Leica Biosystems Newcastle Ltd, United Kingdom), desmin (mouse anti-human monoclonal desmin antibody, clone DE-R-11, Leica Biosystems Newcastle Ltd, United Kingdom), multi-cytokeratin (mouse anti-human multi-cytokeratin antibody, clone AE1/AE3, Leica Biosystems Newcastle Ltd, United Kingdom), α-smooth muscle actin (rabbit polyclonal alpha-smooth muscle actin antibody, product code: ab5694, Abcam, United Kingdom), S100 (rabbit polyclonal S-100 antibody, Leica Biosystems Newcastle Ltd, United Kingdom) and CD45 (mouse anti-human monoclonal antibody, clone X16/99, Leica Biosystems Newcastle Ltd, United Kingdom). All samples were processed using the automatic Leica Bondmax TM Immunohistochemistry system (Leica Biosystems Melbourne, Bond Max model, M2 12154 series). Eventually, the obtained samples were counterstained by Mayer's hematoxylin. For all biomarkers applied, were considered positive the tumor cells that had the cytoplasm (vimentin, desmin, multicytokeratin, actin, S-100) or plasma membrane (CD45) marked in various levels of brown. For higher accuracy, the negative and positive controls were used. All samples were assessed using the Olympus BX51 microscope that was linked to an Olympus SP-350 photo-camera; the image analysis was performed with the aid of Olympus Cell B software (Olympus Corporation, Japan).
In all tumors assessed, immunohistochemistry showed an intense reaction only for vimentin in all neoplastic cells (including multinucleated giant cells; Figure 2E and F). Concerning the other biomarkers, the IHC-reaction was negative in all masses (Table 1) .
Table 1. Immunohistochemical results of the analyzed tumoral masses

Vimentin Desmin S-100
Multicytokeratin α-smooth muscle actin CD45
Based on the history, gross, cytological, histological and immunohistochemical data, the fi nal diagnosis was recurrent FISF (feline injection-site fi brosarcoma), with multiple metastases (including in the cerebellum).
DISCUSSIONS
FISS were regularly observed in body regions typically exposed to injection (e.g., interscapular, dorsolateral thoracic region, hind limbs and lumbar region), and occasionally in the ventral thoracic and abdominal regions [4] . FISS are aggressive and locally infi ltrative tumors, facts that make diffi cult a complete surgical excision [4, 11] . An increase in survival rate is closely related to early surgical intervention and radical excision. Thus, a survival rate of up to 576 days after surgery was reported [4, 12] . However, even after a wide surgical excision, the relapse rate of FISS is high (45%) [2, 13] .
The metastatic rate of FISS varies from 10% in more recent studies, to 25% in older reports, with a much higher incidence compared to sarcomas that are not associated with vaccinations [8, 12, [14] [15] [16] . Generally, FISS metastasize to the lungs, but other locations were also reported, such as regional lymph nodes, mediastinum, liver and omentum [8, 11, 17, 18] . Histologically, FISS may contain seldom large macrophages that display in the cytoplasm a blue to greyish material, most likely due to ingestion of adjuvant substances [20, 21] . Such macrophages were observed in less than 50% of FISS [22, 23, 24] . No such macrophages were observed in our study. As we observed in our subject, a follicular infi ltrate composed of lymphocytes and plasma cells can be identifi ed in the peripheral zone of FISSs [21, 25] . The role of these lymphocytes in tumorigenesis and/or host response is unknown [26] . Another feature identifi ed in the tumoral masses of the presented cat were the neoplastic multinucleated giant cells, which are common in FISS. Usually, they reveal a less differentiated tumor phenotype [26, 27] .
In most situations, FISS are resembling fi brosarcomas that represent up to 80-90% of all cases. However, other sarcoma types were reported, such as: osteosarcoma, condrosarcoma, myxosarcoma, rhabdomyosarcoma, malignant fi brous histiocytoma, myofi broblastic sarcoma and undifferentiated sarcoma [3, 8, 15, 22, 24, [26] [27] [28] [29] [30] .
All FISF express only vimentin [4] , an aspect observed in our case too. However, in some FISF, the reactive multinucleated giant cells can express leukocyte markers CD45 and CD18, while the giant cells derived from fi broblasts express only vimentin. Myofi broblastic fi brosarcomas express α-smooth muscle actin, and rarely they can be positive for desmin. Histiocytic sarcomas are positive for CD45 and CD18, whereas leiomyomas express the both α-smooth muscle actin and desmin. According to that, the differentiation of myofi broblastic fi brosarcomas from leiomyomas cannot be made using immunohistochemistry [4] .
Overall, an uncommon case of FISF has been reported. This is the fi rst consistent record of an injection site sarcoma in cat with cerebellar metastasis. Herein we present gross, cytologic, histopathologic and immunohistochemical features of a FISF with brain invasion. Hendrick i Goldscmidt su 1991. godine prvi opisali sarkome na injekcionim situsima kod mačaka. Pojava sarkoma na mestu vakcinacije, uslovila je da se ustali poseban termin -vakcinalni sarkom. U studiji se opisuje neobičan slučaj fi brosarkoma na mestu inokulacije uz postojanje metastazau malom mozgu. Radilo se o domaćoj kratkodlakoj mački staroj 7 godina koja je primljena na obdukciju na Katedru za patologiju, Fakulteta veterinarske medicine u Cluj-Napoca (Rumunija). Uočen je supkutani tumor (relaps) u interskapularnoj regiji kao i veći broj metastaza u plućima, bubrezima, potkožnom tkivu (regije skapule i ekstremiteta) kao i u cerebelumu. Obavljena su citološka, histološka i imunohistohemijska ispitivanja (na vimentin, dezmin, citokeratin, α-aktin glatkih mišića, S100 i CD45) svih uzoraka tkiva tumora. Citološkim ispitivanjem, uočene su izrazito pleomorfne, vretenaste ćelije zajedno sa neoplastičnim multijedarnim gigantocitima. Histološki, sve neoplastične mase su se sastojale iz većeg broja vretenaste ćelija koje su bile organizovane u ispreplitane grupice. U tkivima tumora, bila je naglašena nekroza zajedno sa infi ltracijom neutofi la. Zajedno sa neoplastičnim ćelijama uočene su fi brilarne strukture (zeleno obojene primenom Masson-ove trihrom metode), što ukazuje na kolagenu strukturu. Kod svih tumorskih tkiva koja su ispitivana imunohistohemijski, bila je uočena intenzivna reakcija samo na vimentin i to kod većeg broja neoplastičnih ćelija. Na osnovu anamneze, patomorfološkog, citološkog, histološkog i imunohistohemijskog nalaza, postavljena je konačna dijagnoza tj. rekurentan fi brosarkom injekcionog situsa mačaka uz postojanje brojnih metastaza (uključujući i cerebelum). Opisan je neobičan slučaj fi brosarkoma injekcionog situsa mačaka. Radi se o prvom opisanom slučaju sarkoma injekcionog situsa mačaka sa metastazama u cerebelumu.
